Stephens restated their overweight rating on shares of Establishment Labs (NASDAQ:ESTA - Free Report) in a research report sent to investors on Thursday,Benzinga reports. Stephens currently has a $52.00 target price on the stock.
Establishment Labs Stock Down 12.0 %
Shares of NASDAQ ESTA traded down $5.01 during mid-day trading on Thursday, reaching $36.69. The company had a trading volume of 835,990 shares, compared to its average volume of 416,988. Establishment Labs has a 12-month low of $28.16 and a 12-month high of $60.12. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The company has a market capitalization of $1.06 billion, a price-to-earnings ratio of -14.22 and a beta of 0.95. The stock has a fifty day moving average of $37.37 and a two-hundred day moving average of $41.34.
Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). The business had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. As a group, equities research analysts expect that Establishment Labs will post -2.41 EPS for the current year.
Institutional Investors Weigh In On Establishment Labs
Several hedge funds have recently bought and sold shares of ESTA. Quarry LP bought a new position in shares of Establishment Labs in the 4th quarter valued at about $27,000. R Squared Ltd bought a new stake in shares of Establishment Labs during the 4th quarter valued at $36,000. Point72 Asia Singapore Pte. Ltd. bought a new position in Establishment Labs in the third quarter valued at approximately $127,000. KLP Kapitalforvaltning AS bought a new stake in shares of Establishment Labs during the 4th quarter worth $161,000. Finally, Hood River Capital Management LLC lifted its stake in shares of Establishment Labs by 236.4% in the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company's stock valued at $273,000 after acquiring an additional 4,160 shares during the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.
About Establishment Labs
(
Get Free Report)
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
Featured Stories
Before you consider Establishment Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.
While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
